We are live on
!
Find out more
AL
Aspiriant LLC Portfolio holdings
AUM
$3.51B
1-Year Est. Return
13.98%
This Fund
S&P 500
This Quarter
Est. Return
-0.73%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$3.51B
AUM Growth
+$30.4M
(+0.87%)
Cap. Flow
+$70M
Cap. Flow
% of AUM
1.99%
Top 10 Holdings %
Top 10 Hldgs %
63.99%
Holding
355
New
36
Increased
103
Reduced
149
Closed
17
Top Buys
| 1 |
Vanguard Small-Cap Value ETF
VBR
|
+$26.6M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$23.2M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$10.6M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.64M |
| 5 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$3.92M |
Top Sells
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.54M |
| 2 |
Apple
AAPL
|
+$3M |
| 3 |
Microsoft
MSFT
|
+$2.43M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$1.8M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.61M |
Sector Composition
| 1 | Technology | 3.46% |
| 2 | Financials | 2.08% |
| 3 | Communication Services | 1.14% |
| 4 | Healthcare | 0.74% |
| 5 | Industrials | 0.62% |
Similar funds
BCP
ACA
IIM
TH
TYCC
TCM
DILIC
KCM
Aspiriant LLC's Q1 2026 Portfolio in Review
As of Q1 2026, Aspiriant LLC held 355 positions worth $3.51B, up 0.87% from $3.48B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Aspiriant LLC's Q1 2026 filing shows 36 new, 103 increased, 149 reduced and 17 closed positions. Its largest new stake was Rhythm Pharmaceuticals: 33,007 shares worth $2.87M. The largest sale was Vanguard Tax-Exempt Bond Index Fund, an estimated $3.54M.
By sector, the portfolio is most concentrated in Technology at 3.5% of assets, down from 4.1% a quarter earlier, followed by Financials and Communication Services.
- Aspiriant LLC's largest Q1 2026 buy was Rhythm Pharmaceuticals: 33,007 shares worth $2.87M.
- Aspiriant LLC added most to Vanguard Small-Cap Value ETF in Q1 2026, an estimated $26.6M increase.
- Aspiriant LLC's biggest Q1 2026 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $3.54M.
- Aspiriant LLC fully exited Brookfield in Q1 2026, selling an estimated $957K.
- Aspiriant LLC's ten largest holdings make up 64% of its $3.51B portfolio in Q1 2026.
- Aspiriant LLC opened 36 new positions and closed 17 in Q1 2026.
- Aspiriant LLC's portfolio value rose 0.87% quarter-over-quarter to $3.51B.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.